Management of Obstructive Jaundice Exper PDF
Management of Obstructive Jaundice Exper PDF
Management of Obstructive Jaundice Exper PDF
ABSTRACT
Objective: To evaluate the presentation, clinical features and treatment of Obstructive Jaundice cases.
Design & Duration: Prospective observational study from Jan. 2003 to Dec. 2004.
Setting: Surgical Unit IV, Civil Hospital, Karachi.
Patients: All patients who were admitted and treated for Obstructive Jaundice.
Methodology: The patients were evaluated clinically and by investigations. After appropriate preparations surgery
was carried out; the procedure depending upon the nature of the lesion. Intra and post-operative complications, and
the outcome of the patient was noted and the whole data analyzed.
Results: This study comprises of 24 cases of Obstructive Jaundice. Their ages varied from 25-65 years (mean age
being 41.12 years); 10 were males and 12 females. Amongst these 13 (54.17%) patients had jaundice due to malig-
nancy, 9 (37.5%) had stones in the common bile duct (CBD) and the remaining 2 (8.33%) patients had amoebic liver
abscesses. In the malignant group five patients had Carcinoma Head of the Pancreas (two treated by pancreato-
duodenectomy and three by cholecystojejunostomy), three had Cholangiocarcinoma (treated by hepatojejunostomy),
three had Carcinoma Gall bladder (one treated by hepatojejunostomy, two inoperable) and two patients with malignant
nodes at the porta hepatis who refused surgery and were referred for endoprostheses. All patients with stones in the
CBD were treated by cholecystectomy and choledocholithotomy, whereas those with amoebic liver abscess underwent
drainage/aspiration.
Conclusion: Early diagnosis of the cause of obstruction is very important especially in malignant cases, as resection
is only possible at that stage.
KEY WORDS: Obstructive Jaundice, Choledocholithiasis, Carcinoma Pancreas, Cholangiocarcinoma, Liver Abscess
In our study 13 (54.17%) patients had jaundice due to 1999 Oct-Dec; 20(4): 167-9.
malignancy; out of these in nine (37.5%) patients curative
surgery was not possible. Seven (29.17%) patients, how 4. Gores GJ. Early detection and treatment of Cholan-
ever, underwent palliative bypass surgery; three with giocarcinoma. Liver Transpl 2000; 6-S: 30-34.
Ca. Head of Pancreas had cholecystojejunostomy, while
three with cholangiocarcinoma and one with Ca. Gall 5. Khan SA, Davidson BR, Goldin R, et al. Guidelines
bladder had hepaticojejunostomy. Two with nodes in for the diagnosis and treatment of Cholangiocarci-
the porta hepatis refused surgery and were advise endo- noma: Consensus document. Gut 2002; 51: 1-9.
prosthesis. Fortner9 in his study on 52 patients with
obstructive jaundice reported palliative procedures in 6. Provoski SP, Karpeh M Jr, Conlon KC, et al. Pre-
38 (73.1%) cases including endoprosthesis placement operative biliary drainage: Impact on intra-opera
in 22 (42.31%) and bypass surgery in 16 (30.8%) cases. tive bile cultures and infectious morbidity and mor-
Other authors have also quoted similar figures10-14. tality. J Gastrointest Surg 1999; 3: 496-505.
In the study nine patients had jaundice due to stones in 7. Tompkins RK, et al. Changing pattern in the diag-
the common bile duct; they underwent choledocholitho- nosis and management of Bile duct Cancer. Ann
tomy and T-tube insertion. No complication was noted Surg 1990; 211: 614-621.
except bile leakage from around the T-tube in one case.
Pappas et al15 reported choledocholithotomy and T-tube 8. De Groen PC, Gores GJ, La Russo NF, et al. Biliary
insertion in 93 out of 95 patients; five (5.26%) cases tract Cancers. N Engl J Med 1999; 341: 1368-79.
had retained stones.
9. Fortner JG. Proximal extrahepatic bile duct tumors.
CONCLUSION Arch Surg 1989; 143: 1275-1279.
Early diagnosis of the cause of obstruction is very im- 10. Hadjis NS, Collier NA, Blumgart LH, Malignant
portant especially in malignant cases. For this there masquerade at the hilum of liver. Br J Surg 1985;
should be trained staff at primary care health centers 72: 659-661.
all over the country. Cholecystectomy & exploration
of CBD remains the first line of therapy for stone disease 11. Blumgart LH, Hadjis NS, Benjamin IS, Beazley R.
of gall bladder and bile ducts. In malignant jaundice, Surgical approaches to Cholangiocarcinoma at the
resection is only possible when the diagnosis is made confluence of hepatic ducts. Lancet 1984; 1: 66.
early, otherwise palliation is only alternative.
12. Stain SC, Baer HU, Dennison AR, et al. Current
REFERENCES management of hilar Cholagiocarcinoma. Surg Gy-
necol Obstet 1992; 175: 578-579.
1. Kelson DP, Portenoy R, Thalor H, et al. Pain as a
predictor of outcome in patients with operable Pan- 13. Nimura Y, Kamiya J, Ngino M, et al. Aggressive
creatic Carcinoma. Surgery 1997; 122: 53-59. surgical treatment of the hilar Cholangiocarcinoma.
J Hepatobiliary Pancreat Surg 1998; 5: 52-61.
2. Magnuson TH, Bender JS, Duncan MD, et al. Uti-
lity of Magnetic Resonance Cholangio-Pancreato- 14. Wagner M, et al. Stent or Surgical bypass as pallia-
graphy in the evaluation of Biliary obstruction. J tive therapy in Obstructive Jaundice. Swiss Surg
Am Coll Surg 1999; 189: 63-72. 2000; 6(5): 283-8.
3. Sharma MP, et al. Aetiological spectrum of Obstruc- 15. Pappas TN, Slimane TB, Brooks DC. 100 conse-
tive Jaundice and the diagnostic ability of ultrasono- cutive common bile duct explorations without mor-
graphy: A clinician’s perspective. Trop Gastroenterol tality. Ann Surg 1990; 211: 260-262.